Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
United Greeneries was a pioneer in the Canadian cannabis industry, being one of the first licensed producers. Formerly a subsidiary of MMJ PhytoTech, the company's cultivation and processing businesses were acquired in 2020 by Costa Canna Production LLP and 626875 B.C. Ltd. for $8.2 million, after which they entered a license agreement for Cannabis 2.0 products.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on United Greeneries.